Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised controlled Evaluation of Home treatment for Older People with Mental Illness
ISRCTN ISRCTN03613183
ClinicalTrials.gov identifier
Public title Randomised controlled Evaluation of Home treatment for Older People with Mental Illness
Scientific title
Acronym N/A
Serial number at source N0195177177
Study hypothesis 1. By means of a randomised controlled trial. We will evaluate the impact of home treatment of older individuals with severe mental illness on: A. bed occupancy and admission rates. B. satisfaction, Quality of life and Mental Health. C. Adverse outcomes. D. Mental Health and quality of life of carers.
2. By means of a cross-sectional survey using a semi-structured interview with purposive sampling, we will identify stakeholder views on the home treatment service with particular emphasis on: A. Problems with introduction of home treatment in this service. B. Issues of establishing home treatment to other services.
3. Using a combination of qualitative and quantitative data from (1) and (2) above, we will ascertain those elements of the treatment service that are judged to be of value from the perspective of service providers and consumers. The null Hypothesis for the study is that intensive home treatment of older people with mental illness confers no advantages in terms of outcome, satisfaction, quality of life or costs compared with usual care.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled parallel group trial
Countries of recruitment United Kingdom
Disease/condition/study domain Mental and Behavioural Disorders: Mental illness
Participants - inclusion criteria 1. Age 65 and over living in North Kensington or Westminster
2. Able to give informed consent (or assent if unable to give real consent)
3. Adequate English to complete questionnaires
4. The participant meets the operational criteria for admission to the home treatment team which is mental illness/impairment or personality disorder with one or more of the following:
4.1 Risk of suicide/self harm, self neglect,harm to others and or loss of contact to the service
4.2.Non-adherence to therapy
4.3 Institution of new therapy
4.4 Stabilisation of mental state
4.5 Observation of mental state
4.6 Relief/respite for carers
4.7 Faciltate early discharge
Participants - exclusion criteria Admission to continuing care or long term in-patient.
Anticipated start date 01/03/2005
Anticipated end date 28/02/2006
Status of trial Stopped
Patient information material
Target number of participants 50 outpatients
Interventions Participants will be recruited to the study at the point an admission is considered by the clinicians and randomised to home treatment as usual (2:1). Treatment will be for up to 8 weeks and participants will be evaluated at baseline, 8 weeks and 6 months.
Delivery of a multi-disciplinary intensive home treatment service versus usual care.

Added 21 August 2008: the trial was stopped in August 2005 due to very poor recruitment.
Primary outcome measure(s) 1. Administrative data, mental health, quality of life
2. Psychiatric hospital bed days
3. Proportion of patients admitted
Secondary outcome measure(s) 1. Quality of Life (EQ5D)
2. Functioning (Global Assessment Functioning Scale)
3. Partnerships in Care (Helping Alliances)
4. Poly pharmacy medication proforma
5. Service Utilisation (proforma)
6. Residency
Sources of funding London West Mental Health R&D Consortium, CNWL Mental Health Trust (UK)
NHS R&D Support Funding
Trial website
Publications
Contact name Dr  James  Warner
  Address Psychiatry
Imperial College London, Charing Cross Campus
Claybrook Centre, St Dunstans Road
Hammersmith
  City/town London
  Zip/Postcode W6 8RP
  Country United Kingdom
  Tel +44 07970 849818
  Fax +44
  Email j.warner@imperial.ac.uk
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 29/09/2006
Last edited 05/10/2011
Date ISRCTN assigned 29/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central